ACE — Ascelia Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK393.94m
- SEK360.74m
Brief: Ascelia Pharma Q3 Operating Loss Widens To SEK 16.3 Mln
Brief: Ascelia Pharma: EMA Confirms Mangoral Eligible For The Centralized Regulatory Procedure In The EU
Brief: Ascelia Pharma Upgrades Estimate Of Addressable Market For Mangoral
Brief: Ascelia Pharma: First Commercial Scale Manufacturing Of Mangoral
Brief: Ascelia Pharma Q2 Oper Loss Widens To SEK 28.6 Mln
Brief: Ascelia Pharma Provides Updated SPARKLE Timelines Due To Covid-19 Impact
Brief: Ascelia Q1 Operating Loss Widens To SEK 20.7 Mln
Brief: Ascelia Pharma Gets Patent For Oncoral In Japan
Brief: Ascelia Pharma Says Is In A Solid Financial Situation With 184 MSEK In Liquidity As Of Beginning Of 2020
Brief: Ascelia Pharma Oct-Dec Operating Loss SEK 22.9 Mln
Brief: Ascelia Pharma Oct-Dec Operating Loss Widens To SEK 22.9 Mln
Brief: Ascelia Pharma Opens Five Sites In Phase III Study
Brief: Ascelia Pharma Q1 Operating Loss Widens To SEK 13.9 Mln
Brief: Ascelia Pharma Q4 Operating Loss Widens To SEK 14.5 Million
Brief: Ascelia Pharma Files Patent Application For Next Generation Mangoral Product
Brief: Ascelia AB Q3 Operating Loss Of SEK 11.7 Mln
Brief: Ascelia Pharma Received Supportive Feedback From EMA On Phase 3 Program For Mangoral
Brief: Ascelia Pharma says during April, registered number of shares and votes in co has increased